Promising Compounds From Murraya Exotica for Cancer Metastasis Chemoprevention

Overview

Journal Integr Cancer Ther

Publisher Sage Publications

Specialties Oncology
Pharmacology

Date 2016 Nov 24

PMID 27879377

Citations 2

Authors

Su-Dan He

Xing-Tian Yang

Cui-Cui Yan

Zhou Jiang

Su-Hong Yu

Yu-Yang Zhou

Lee Jia

Affiliations

Soon will be listed here.

Abstract

Most of the present anticancer drugs are highly cytotoxic and focus mainly on killing tumor cells rather than slowing the progress of cancer metastasis. Evidence has been reported that bridges the mechanisms of inflammation and tumor invasion. Therefore, we evaluated the potency in cancer metastasis chemoprevention of compounds and a coumarin extracted from Murraya exotica, which is known for its anti-inflammation bioactivity. By carrying out experiments in vitro, we found the root extracts more efficient than the leaf extracts in restraining cell migration of MDA-MB-231 cells, while leaf extracts presented slightly stronger inhibition of tumor cell adhesion at low concentrations. In addition, compared to root extracts, a novel coumarin identified previously from root extracts showed equal inhibition on cancer cell adhesion and less inhibition on cell migration. All extracts used in this study presented low cytotoxicity in vitro. Through comparison of the contents of leaf and root extracts from M exotica, several compounds are considered promising against cancer metastasis. This study evaluates the worth of further development of M exotica to find its effect on cancer metastasis chemoprevention.

Citing Articles

A comprehensive review of the botany, phytochemistry, pharmacology, and toxicology of Murrayae Folium et Cacumen.

Qi Y, Wang L, Wang N, Wang S, Zhu X, Zhao T Front Pharmacol. 2024; 15:1337161.

PMID: 38606170 PMC: 11007094. DOI: 10.3389/fphar.2024.1337161.

antiplasmodial activity of selected plants from the Colombian North Coast with low cytotoxicity.

Vergara S, Diaz F, Diez A, Bautista J, Moneriz C Trop Parasitol. 2023; 12(2):78-86.

PMID: 36643988 PMC: 9832501. DOI: 10.4103/tp.tp_9_22.

References

Saeed S, Shah S, Mehmood R, Malik A . Paniculacin, a new coumarin derivative from Murraya paniculata. J Asian Nat Prod Res. 2011; 13(8):724-7. DOI: 10.1080/10286020.2011.586343. View

Jiang Z, Yang J, Pang Y, Yang X, Yu S, Jia L . Bioactivity-guided fast screen and identification of cancer metastasis chemopreventive components from raw extracts of Murraya exotica. J Pharm Biomed Anal. 2015; 107:341-5. DOI: 10.1016/j.jpba.2015.01.023. View

Yang H, Zhou Q, Peng C, Liu L, Xie X, Xiong L . [Coumarins from Leonurus japonicus and their anti-platelet aggregative activity]. Zhongguo Zhong Yao Za Zhi. 2015; 39(22):4356-9. View

Huang H, Lai M, Wang H, Chung Y, Hsieh L, Chen C . Antiproliferative effect of esculetin on vascular smooth muscle cells: possible roles of signal transduction pathways. Eur J Pharmacol. 1993; 237(1):39-44. DOI: 10.1016/0014-2999(93)90090-5. View

Dinarello C . Why not treat human cancer with interleukin-1 blockade?. Cancer Metastasis Rev. 2010; 29(2):317-29. PMC: 2865633. DOI: 10.1007/s10555-010-9229-0. View

Bucolo C, Cuzzocrea S, Mazzon E, Caputi A . Effects of cloricromene, a coumarin derivative, on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci. 2003; 44(3):1178-84. DOI: 10.1167/iovs.02-0559. View

Narod S, Risch H, Moslehi R, Dorum A, Neuhausen S, Olsson H . Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med. 1998; 339(7):424-8. DOI: 10.1056/NEJM199808133390702. View

Jones J, Gockerman A, Busby Jr W, Wright G, Clemmons D . Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A. 1993; 90(22):10553-7. PMC: 47815. DOI: 10.1073/pnas.90.22.10553. View

Chen C, Chan H, Chu Y, Ho H, Chen P, Lee T . Antioxidant activity of some plant extracts towards xanthine oxidase, lipoxygenase and tyrosinase. Molecules. 2009; 14(8):2947-58. PMC: 6254854. DOI: 10.3390/molecules14082947. View

10.

Damsky C, Librach C, Lim K, Fitzgerald M, McMaster M, Janatpour M . Integrin switching regulates normal trophoblast invasion. Development. 1994; 120(12):3657-66. DOI: 10.1242/dev.120.12.3657. View

11.

Nakamura T, Kodama N, Oda M, Tsuchiya S, Arai Y, Kumamoto T . The structure-activity relationship between oxycoumarin derivatives showing inhibitory effects on iNOS in mouse macrophage RAW264.7 cells. J Nat Med. 2008; 63(1):15-20. DOI: 10.1007/s11418-008-0268-6. View

12.

Witte D, Harris R, Jenski L, Lampkin B . Megakaryoblastic leukemia in an infant. Establishment of a megakaryocytic tumor cell line in athymic nude mice. Cancer. 1986; 58(2):238-44. DOI: 10.1002/1097-0142(19860715)58:2<238::aid-cncr2820580207>3.0.co;2-#. View

13.

Rhim A, Mirek E, Aiello N, Maitra A, Bailey J, McAllister F . EMT and dissemination precede pancreatic tumor formation. Cell. 2012; 148(1-2):349-61. PMC: 3266542. DOI: 10.1016/j.cell.2011.11.025. View

14.

Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K . The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol. 2008; 10(11):1349-55. DOI: 10.1038/ncb1794. View

15.

Wu L, Liu H, Zhang R, Li L, Li J, Hu H . Chondroprotective Activity of Murraya exotica through Inhibiting β -Catenin Signaling Pathway. Evid Based Complement Alternat Med. 2014; 2013:752150. PMC: 3880701. DOI: 10.1155/2013/752150. View

16.

Ley K, Laudanna C, Cybulsky M, Nourshargh S . Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007; 7(9):678-89. DOI: 10.1038/nri2156. View

17.

Karnoub A, Dash A, Vo A, Sullivan A, Brooks M, Bell G . Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007; 449(7162):557-63. DOI: 10.1038/nature06188. View

18.

Kontogiorgis C, Hadjipavlou-Litina D . Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg Med Chem Lett. 2004; 14(3):611-4. DOI: 10.1016/j.bmcl.2003.11.060. View

19.

Danen E, ten Berge P, van Muijen G, Brocker E, Ruiter D . Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology. 1994; 24(3):249-56. DOI: 10.1111/j.1365-2559.1994.tb00517.x. View

20.

BRETSCHER M . Getting membrane flow and the cytoskeleton to cooperate in moving cells. Cell. 1996; 87(4):601-6. DOI: 10.1016/s0092-8674(00)81380-x. View